‘Why do we have to be the gatekeepers?’ Australian general practitioner’s knowledge, attitudes and prescribing intentions on e-cigarettes as a smoking cessation aid

Author:

Selamoglu Melis1,Erbas Bircan2,Wilson Hester3,Barton Chris1

Affiliation:

1. Monash University

2. La Trobe University

3. UNSW Sydney

Abstract

Abstract Background: A significant policy change impacting the availability of nicotine for use in electronic cigarettes (e-cigarettes) in Australia took effect from October 1, 2021. This change meant that nicotine containing liquids for use with e-cigarettes would only be available by prescription from a medical practitioner as part of a smoking cessation plan. This study aimed to explore General Practitioner’s (GP’s) perceptions about the role of e-cigarettes, and understand factors informing their intentions to prescribe nicotine e-liquid as part of a smoking cessation plan. Methods: In-depth semi-structured interviews were conducted with thirteen GP’s. Purposeful sampling was used to recruit participants. Interviews were audio recorded and transcribed verbatim. Thematic analysis was used to classify, describe and report themes in the data. QSR NVivo was used to aid coding, thematic analysis and retrieval of quotes. Results: Australian GP’s had diverse views on recommending e-cigarettes as smoking cessation aids to patients and prescription of nicotine e-liquid. Some GP’s were willing to prescribe nicotine e-liquid for e-cigarettes to patients if other methods of smoking cessation had not worked but there were concerns, and uncertainty, about the safety and efficacy of e-cigarettes for smoking cessation. There was poor understanding of the current policy and legislation about e-cigarettes in Australia. Mostly the GP’s in this sample did not feel confident or comfortable to prescribe, or have discussions about e-cigarettes with patients. Conclusion: Australian GP’s have diverse attitudes on recommending e-cigarettes for smoking cessation and prescribing nicotine e-liquids. Clarity in guidelines and consumer product information are required to enable GP’s to provide consistent and accurate advice to patients that wish to use e-cigarettes as a smoking cessation aid.

Publisher

Research Square Platform LLC

Reference36 articles.

1. Australian Institute of Health and Welfare. Alcohol, tobacco & other drugs in Australia. 2022 14 December 2022 14 February 2022]; Available from: https://www.aihw.gov.au/reports/alcohol/alcohol-tobacco-other-drugs-australia/contents/drug-types/tobacco.

2. Challenges and opportunities for tobacco control in Australia: a qualitative study;Jongenelis MI;Aust N Z J Public Health,2022

3. Department of Health and Aged Care. Smoking and tobacco laws in Australia. 2021 11 August 2021 [cited 2023 14 February]; Available from: https://www.health.gov.au/topics/smoking-and-tobacco/about-smoking-and-tobacco/smoking-and-tobacco-laws-in-australia#:~:text=The%20Tobacco%20Advertising%20Prohibition%20Act,retail%20display%20of%20tobacco%20products.

4. Campaign for Tobacco-Free Kids. Electronic cigarettes: An overview of key issues. 2021 [cited 2022 March 9]; Available from: https://www.tobaccofreekids.org/assets/factsheets/0379.pdf.

5. The Union. Where bans are best: Why LMICs must prohibit e-cigarette and HTP sales to truly tackle tobacco. 2020 [cited 2022 March 9]; Available from: https://theunion.org/sites/default/files/2020-08/TheUnion_TobaccoControl_E-CigPaper_English_07.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3